S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
NASDAQ:ZYNE

Zynerba Pharmaceuticals (ZYNE) Earnings Date, Estimates & Call Transcripts

$0.34
+0.02 (+6.25%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.32
▼
$0.34
50-Day Range
$0.30
▼
$0.44
52-Week Range
$0.30
▼
$1.60
Volume
193,848 shs
Average Volume
220,253 shs
Market Capitalization
$18.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(May. 15)
-$0.21 Missed By -$0.02
Consensus EPS
(May. 15)
-$0.19
Last Year's Q2 EPS
(5/16/2022)
-$0.21
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ZYNE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ZYNE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Zynerba Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.20)($0.20)($0.20)
Q2 20231($0.20)($0.20)($0.20)
Q3 20231($0.21)($0.21)($0.21)
Q4 20231($0.22)($0.22)($0.22)
FY 20234($0.83)($0.83)($0.83)
Q1 20241($0.22)($0.22)($0.22)
Q2 20241($0.18)($0.18)($0.18)
Q3 20241($0.20)($0.20)($0.20)
Q4 20241($0.28)($0.28)($0.28)
FY 20244($0.88)($0.88)($0.88)

ZYNE Earnings Date and Information

Zynerba Pharmaceuticals last posted its earnings data on May 15th, 2023. The reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.02. Zynerba Pharmaceuticals has generated ($0.83) earnings per share over the last year (($0.83) diluted earnings per share). Earnings for Zynerba Pharmaceuticals are expected to grow in the coming year, from ($0.78) to ($0.61) per share. Zynerba Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off prior year's report dates.

Zynerba Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2023
(Estimated)		        
5/15/20233/31/2023($0.19)($0.21)($0.02)($0.21)
3/28/2023Q4 2022($0.24)($0.18)+$0.06($0.18)
11/14/2022Q3 2022($0.21)($0.20)+$0.01($0.20)
8/10/2022Q2 2022($0.21)($0.24)($0.03)($0.24)
5/16/2022Q1 2022($0.22)($0.21)+$0.01($0.21)
3/1/2022Q4 2021($0.27)($0.22)+$0.05($0.22)
11/15/20219/30/2021($0.25)($0.26)($0.01)($0.26)
8/9/20216/30/2021($0.22)($0.25)($0.03)($0.25)
5/12/20213/31/2021($0.25)($0.20)+$0.05($0.20)
3/10/202112/31/2020($0.32)($0.33)($0.01)($0.33)
11/9/20209/30/2020($0.43)($0.31)+$0.12($0.31)
8/10/20206/30/2020($0.45)($0.78)($0.33)($0.78)
5/11/20203/31/2020($0.50)($0.53)($0.03)($0.53)
3/10/202012/31/2019($0.50)($0.46)+$0.04($0.46)
11/6/2019Q3($0.5210)($0.44)+$0.0810($0.08)
8/6/2019Q2 2019($0.4950)($0.5035)($0.0085)($0.50)
5/8/20193/31/2019($0.49)($0.47)+$0.02($0.47)
3/11/201912/31/2018($0.65)($0.44)+$0.21($0.44)$0.09 million
11/8/20189/30/2018($0.70)($0.47)+$0.23($0.47)
8/2/2018Q2 2018($0.77)($0.89)($0.12)($0.89)
5/8/2018Q1 2018($0.6770)($0.91)($0.2330)($0.91)
3/12/2018Q4 2017($0.60)($0.60)($0.60)
11/14/2017Q3 2017($0.5850)($0.6340)($0.0490)($0.63)
8/1/2017Q2 2017($0.60)($0.64)($0.04)($0.64)$0.38 million
5/9/2017Q1 2017($0.5460)($0.60)($0.0540)($0.60)$0.07 million
3/27/2017Q4 2016($0.73)($0.71)+$0.02($0.71)
11/14/2016Q3 2016($0.67)($0.67)($0.67)$0.20 million
8/11/2016Q2 2016($0.53)($0.70)($0.17)($0.70)$0.03 million
5/12/2016Q1 2016($0.54)($0.49)+$0.05($0.49)$0.03 million$0.01 million
3/14/2016Q4 2015($0.59)($0.62)($0.03)($0.62)$0.20 million$0.05 million
11/11/2015Q3 2015($0.41)($0.58)($0.17)($0.50)$0.20 million
8/27/2015Q2 2015($0.80)($0.80)($0.80)$0.02 million












Zynerba Pharmaceuticals Earnings - Frequently Asked Questions

When is Zynerba Pharmaceuticals's earnings date?

Zynerba Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off last year's report dates. Learn more on ZYNE's earnings history.

Did Zynerba Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Zynerba Pharmaceuticals (NASDAQ:ZYNE) missed the analysts' consensus estimate of ($0.19) by $0.02 with a reported earnings per share (EPS) of ($0.21). Learn more on analysts' earnings estimate vs. ZYNE's actual earnings.

How much profit does Zynerba Pharmaceuticals generate each year?

Zynerba Pharmaceuticals (NASDAQ:ZYNE) has a recorded net income of -$35.04 million. ZYNE has generated -$0.83 earnings per share over the last four quarters.

What is Zynerba Pharmaceuticals's EPS forecast for next year?

Zynerba Pharmaceuticals's earnings are expected to grow from ($0.78) per share to ($0.61) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ZYNE) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -